Balance Sheet Data

Altimmune, Inc. (ALT)

$2.61

+0.05 (+1.95%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 33.7237.24215.92190.30184.8822.4013.988.725.443.40
Total Cash (%)
Account Receivables 4.471.6512.375.842.540.290.180.110.070.04
Account Receivables (%)
Inventories --503.90-1,958.89-13,388.520.0335.6722.2513.898.665.41
Inventories (%)
Accounts Payable 0.370.020.612.034.800.590.370.230.140.09
Accounts Payable (%)
Capital Expenditure -1.02-0.03-0.34-12.31-0.130.010.01000
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.